Niagara Hooker Employees Union v. Occidental Chemical Corporation

935 F.2d 1370, 137 L.R.R.M. (BNA) 2652, 1991 U.S. App. LEXIS 13092, 1991 WL 107275
CourtCourt of Appeals for the Second Circuit
DecidedJune 20, 1991
Docket951, Docket 90-7868
StatusPublished
Cited by36 cases

This text of 935 F.2d 1370 (Niagara Hooker Employees Union v. Occidental Chemical Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Niagara Hooker Employees Union v. Occidental Chemical Corporation, 935 F.2d 1370, 137 L.R.R.M. (BNA) 2652, 1991 U.S. App. LEXIS 13092, 1991 WL 107275 (2d Cir. 1991).

Opinion

WALKER, Circuit Judge:

Defendant-appellant Occidental Chemical Company (“Oxychem”) appeals from an opinion and order of the United States District Court for the Northern District of New York, John T. Elfvin, Judge, preliminarily enjoining it from implementing random urinalysis drug testing of all “safety-sensitive” employees pending arbitration of the Union's grievance, which challenged the program as a violation of the collective bargaining contract. Because we find that the issuance of the preliminary injunction was not authorized by the narrow Boys Markets/Buffalo Forge exception to the Norris-LaGuardia Act, 29 U.S.C. § 101, et seq., we vacate the preliminary injunction.

BACKGROUND

The essential facts are not in dispute. Oxychem manufactures industrial chemicals at its facility in Niagara Falls, New York. Plaintiff-appellee Niagara Hooker Employees Union (the “Union”) is the exclusive bargaining representative of the production and maintenance workers employed at the facility.

Oxychem and the Union entered into a collective bargaining agreement dated September 30, 1988 (the “CBA”), expiring on September 30, 1991. Under the terms of the CBA, parties are to submit disputes concerning working conditions and the application of the CBA's provisions to binding arbitration.

The CBA contains a “Drug and Alcohol Policy” prohibiting the use, possession, purchase, or sale of alcohol or illegal drugs by employees while on the job or on company property. The policy was the subject of lengthy negotiations between the Union and Oxychem. Among other things, it authorizes urinalysis drug testing of an employee if her supervisor reasonably suspects the use of illicit drugs (the “reasonable suspicion” program).

The CBA also contains a “management rights” clause. Article XIV grants Oxy-chem the discretion, absent restrictions by the CBA, to

make and enforce reasonable rules and regulations to promote safety, efficiency, discipline, order and protection of the Company’s employees, operations, property and products from injury, damage or other loss from any source, including sabotage or other subversive activity.

Finally, the CBA contains what is known as a “zipper clause.” Article XVIII provides:

This Agreement represents the full and complete understanding between the Company and the Union. Both parties hereby expressly waive their right to request further negotiations on any provisions contained in this Agreement or to request negotiations on any other subjects for the duration of this Agreement.

Despite the implementation of the “reasonable suspicion” program negotiated with the Union and described in the CBA in September, 1988, Oxychem experienced drug and alcohol-related incidents at the Niagara Falls facility: an employee who was monitoring chemical reactions fell asleep at his post; a truck driver failed to lower a truck bed, which then hit a railroad and chemical pipeline overpass above a public thoroughfare; and a chlorine worker was found injured, lying on a railroad track, unaware of his surroundings. Further, in response to reports of a “drug ring” within the facility in 1988 and 1989, the Niagara County District Attorney’s Office, with Oxychem’s cooperation, conducted an undercover operation at the facility that resulted in the arrest of eight Oxy-chem employees on drug-related charges.

In April 1990, as required by regulations issued by the United States Department of Transportation, Research and Special Program Administration (“DOT”), Oxychem *1373 adopted a second drug-testing program. The DOT program requires that those “safety and security sensitive” employees who work with certain hazardous liquids and gases be subject to pre-employment, periodic, reasonable cause, post-accident, and random testing. 49 C.F.R. pt. 199. The Union has not protested Oxychem’s implementation of the DOT program. The program covers slightly less than half of the more than 900 employees at the facility and chiefly includes only those employees engaged in the off-site transportation of hazardous gases or regulated hazardous liquids.

The DOT program, however, does not cover employees who work with many of the dangerous or toxic chemicals Oxychem produces, such as chlorine, caustic soda, and hydrogen fluoride. Accordingly, Oxy-chem decided to institute a third drug-testing program — the program at issue in this appeal — that would randomly test all safety-sensitive employees (the “random testing program”). The program would apply to employees holding “[a]ny job which may through mental or physical activity affect the safety and welfare of co-workers, the community and/or environment; includes policy-making positions.” The program would use the same testing procedures and lab protocols as those used in the reasonable suspicion program instituted following negotiation with the Union and incorporation in the CBA.

On June 14, 1990, Oxychem informed the Union of its plan to implement the random drug testing program, and requested that the Union negotiate over the specifics of the plan. The Union refused. In a written reply, the Union president stated that the Union had no intention of negotiating a random drug testing program during the term of the current collective bargaining agreement, adding, “Any changes in [the drug and alcohol testing] policy should be addressed in the 1991 Contract negotiations.”

Despite the Union’s refusal to negotiate, Oxychem decided to implement the program effective August 3,1990. On August 1,1990, following the CBA’s procedure, the Union filed a grievance stating that the unilateral implementation of the random drug testing program violated the CBA’s “zipper clause” and drug testing provisions. Both parties agree that the grievance is subject to arbitration under the terms of the CBA.

On August 2, 1990, the Union filed the instant suit under Section 301(a) of the Labor Management Relations Act of 1947 (“LMRA”), alleging violations of the CBA. See 29 U.S.C. § 185(a). The complaint sought a preliminary injunction barring unilateral implementation of the random testing program pending arbitration of the grievance. The Union also moved for a temporary restraining order, which the district court denied upon Oxychem’s. representation that it did not plan to begin its random testing program for several weeks.

On August 13, 1990, the district court heard the motion for preliminary injunction. In support of its motion, the Union submitted an affidavit of Union Vice President Frank Marrone but offered no live testimony in support of its motion.

On August 17, 1990, the district court granted the preliminary injunction.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vsea v. State
Vermont Superior Court, 2025
Brady v. National Football League
644 F.3d 661 (Eighth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
935 F.2d 1370, 137 L.R.R.M. (BNA) 2652, 1991 U.S. App. LEXIS 13092, 1991 WL 107275, Counsel Stack Legal Research, https://law.counselstack.com/opinion/niagara-hooker-employees-union-v-occidental-chemical-corporation-ca2-1991.